NCT01999153

Evaluation of the Analgesic Effect of Ropivacaine in Topical Use at the Thin Skin Graft Donor Site

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 58 (actual)
• Sponsor: University Hospital, Rouen · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The aim of the study is to Evaluate of the analgesic effect of ropivacaine in topical use at the thin skin graft donor site. For Patient needing a thin skin graft \< 320 cm2, randomization will be done in 2 groups, one receiving the standard treatment (20 mL of physiologic serum) during the surgical intervention in topical use to recover an alginate dressing (Algosteril)and the other receive 20 mL of Naropein during the surgical intervention on alginate dressing. The hypothesis of the study is the administration of ropivacaine will decrease the post-operative pain compared to physiologic serum

Conditions

• Graft Pain

Interventions

Type	Name	Description
DRUG	20 mL topically used during alginate dressing NAROPEINE	20 mL topically used during alginate dressing
DRUG	20 mL topically used during alginate dressing NaCl	20 mL topically used during alginate dressing

Timeline

• Start date: 2013-12-09
• Primary completion: 2018-10-04
• Completion: 2018-10-04
• First posted: 2013-12-03
• Last updated: 2026-01-22

Locations

1 site across 1 country: France